Last reviewed · How we verify
Cultivation of Limbal epithelial cells into a graft — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Cultivation of Limbal epithelial cells into a graft (Cultivation of Limbal epithelial cells into a graft) — Massachusetts Eye and Ear Infirmary.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cultivation of Limbal epithelial cells into a graft TARGET | Cultivation of Limbal epithelial cells into a graft | Massachusetts Eye and Ear Infirmary | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cultivation of Limbal epithelial cells into a graft CI watch — RSS
- Cultivation of Limbal epithelial cells into a graft CI watch — Atom
- Cultivation of Limbal epithelial cells into a graft CI watch — JSON
- Cultivation of Limbal epithelial cells into a graft alone — RSS
Cite this brief
Drug Landscape (2026). Cultivation of Limbal epithelial cells into a graft — Competitive Intelligence Brief. https://druglandscape.com/ci/cultivation-of-limbal-epithelial-cells-into-a-graft. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab